Crinetics Pharmaceuticals Inc (NASDAQ:CRNX)
| 13.02 Delayed Data As of Nov 25 |  -0.52 / -3.83%Today’s Change | 10.63 Today|||52-Week Range 26.67 | -48.11% Year-to-Date |
Latest CRNX News | Press Releases
No recent news for Crinetics Pharmaceuticals Inc.
Today’s Trading
| Previous close | 13.59 |
| Today’s open | 13.64 |
| Day’s range | 12.94 - 13.64 |
| Volume | 88,742 |
| Average volume (3 months) | 127,240 |
| Market cap | $450.0M |
Data as of 3:59pm ET, 11/25/2020
Growth & Valuation
| Earnings growth (last year) | +6.60% |
| Earnings growth (this year) | -12.54% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.83 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SPROSpero Therapeutics I... | +0.02 | +0.13% |
| BYSIBeyondspring Inc | +0.55 | +5.32% |
| AVDLAvadel Pharmaceutica... | +0.14 | +1.95% |
| ---- |
Data as of 3:59pm ET, 11/25/2020
Financials
| Next reporting date | March 16, 2021 |
| EPS forecast (this quarter) | -$0.58 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$50.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
